FDA Pilot Aims to Reduce Risk of Diagnostic Tests for Cancer

The FDA expressed concern that some laboratory-developed tests may not be as reliable or perform as well as FDA-authorized tests. The pilot program will provide more scrutiny of these tests.
Medscape Medical News

source https://www.medscape.com/viewarticle/993801?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?